Florian Lordick
Leipzig, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 393 publications
Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions.
Journal: ESMO gastrointestinal oncology
Published: September 03, 2026
Short-term culture of human endoscopic specimens for the study of chronic inflammation.
Journal: Methods in cell biology
Published: September 03, 2026
Zolbetuximab plus pembrolizumab and chemotherapy in CLDN18.2-positive, HER2-negative, PD-L1-positive gastric or gastroesophageal junction adenocarcinoma: randomized, double-blind, phase III LUCERNA trial.
Journal: ESMO gastrointestinal oncology
Published: August 12, 2026
Personalized systemic treatment of metastatic esophageal cancer
Journal: Chirurgie (Heidelberg, Germany)
Published: July 23, 2026
Exploiting the Weak Link: Ataxia-Telangiectasia Mutated Dysfunction in Oesophagogastric Tumours.
Journal: Critical reviews in oncology/hematology
Published: May 21, 2026
Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 13, 2026
UCCL-IKF-AIO-STO-0124 NeoART-an international phase Ib/II platform trial investigating trastuzumab deruxtecan (T-DXd) combined with neoadjuvant chemotherapy for HER2-positive, resectable esophagogastric adenocarcinoma (EGA).
Journal: ESMO gastrointestinal oncology
Published: April 30, 2026
Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons.
Journal: Nature reviews. Clinical oncology
Published: April 24, 2026
Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
FRUQUITAS trial: Study design of an ENGIC intergroup randomized phase III of trifluridine/tipiracil +/- fruquintinib in pre-treated metastatic gastro-oesophageal adenocarcinoma.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: April 03, 2026
Treatment Limitations and Missing Information in Peritoneal Metastatic Gastric Cancer.
Journal: Cancers
Published: March 30, 2026
EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer.
Journal: Translational oncology
Published: March 28, 2026
Last Updated: 09/26/2026